AtriCure, Inc.ATRCNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank44
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P44
Within normal range
vs 5Y Ago
-6.7x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -25.04% |
| Q3 2025 | 23.59% |
| Q2 2025 | 296.05% |
| Q1 2025 | -288.93% |
| Q4 2024 | -70.83% |
| Q3 2024 | 171.06% |
| Q2 2024 | 133.74% |
| Q1 2024 | -642.83% |
| Q4 2023 | 164.78% |
| Q3 2023 | -49.45% |
| Q2 2023 | 173.82% |
| Q1 2023 | -8967.39% |
| Q4 2022 | 102.58% |
| Q3 2022 | -142.18% |
| Q2 2022 | 117.17% |
| Q1 2022 | -8283.39% |
| Q4 2021 | 229.74% |
| Q3 2021 | 94.88% |
| Q2 2021 | 51.34% |
| Q1 2021 | -335.61% |
| Q4 2020 | 3.73% |
| Q3 2020 | 133.01% |
| Q2 2020 | 28.22% |
| Q1 2020 | -355.85% |
| Q4 2019 | -36.25% |
| Q3 2019 | -169.14% |
| Q2 2019 | 127.88% |
| Q1 2019 | -1464.26% |
| Q4 2018 | -81.10% |
| Q3 2018 | 657.54% |
| Q2 2018 | 90.09% |
| Q1 2018 | -717.41% |
| Q4 2017 | 1066.41% |
| Q3 2017 | 112.39% |
| Q2 2017 | 88.93% |
| Q1 2017 | -1354.40% |
| Q4 2016 | -29.28% |
| Q3 2016 | 117.86% |
| Q2 2016 | 44.88% |
| Q1 2016 | -167.92% |